| Dr Arthur R Smolensky, MD | |
|
1700 Medical Center Parkway, St Thomas Rutherford Hopsital, Murfreesboro, TN 37129 | |
| (615) 329-4020 | |
| (615) 327-5475 |
| Full Name | Dr Arthur R Smolensky |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 1700 Medical Center Parkway, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265602999 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 80913 (Arizona) | Secondary |
| 207P00000X | Emergency Medicine | 52714 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Maury Regional Hospital | Columbia, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middle Tennessee Emergency Physicians, P.c. | 3678464526 | 63 |
News Archive
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.
› Verified 8 days ago
| Entity Name | Middle Tennessee Emergency Physicians, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194758979 PECOS PAC ID: 3678464526 Enrollment ID: O20040322001049 |
News Archive
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.
› Verified 8 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050207000666 |
News Archive
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.
› Verified 8 days ago
| Entity Name | App Of Tennessee Ed Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003230236 PECOS PAC ID: 8123251766 Enrollment ID: O20140506000159 |
News Archive
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arthur R Smolensky, MD One Vantage Way, Suite B240, Middle Tennessee Emergency Physicians, Pc, Nashville, TN 37228-1562 Ph: (615) 329-4020 | Dr Arthur R Smolensky, MD 1700 Medical Center Parkway, St Thomas Rutherford Hopsital, Murfreesboro, TN 37129 Ph: (615) 329-4020 |
News Archive
An international research team has used a novel approach to identify genetic factors that appear to influence susceptibility to cholera. The findings by investigators from Massachusetts General Hospital (MGH), the Broad Institute and the International Center for Diarrh-al Disease Research, Bangladesh (ICDDR,B) indicate the importance of pathways involved in regulating water loss in intestinal cells and of the innate immune system in the body's response to the bacteria that causes cholera, which affects from 3 to 5 million people each year and causes more than 100,000 deaths.
A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.
Eating healthy and living well is about more than your waistline. Most people think about the visible impacts that healthy eating have on our lives, yet fail to consider what poor dietary habits can do to our careers.
› Verified 8 days ago
Sherry J Galloway, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Murfreesboro, TN 37130 Phone: 800-596-3455 Fax: 615-396-6963 | |
Mary Jane Brown, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Murfreesboro, TN 37130 Phone: 800-596-3455 Fax: 615-396-6963 | |
Russell E Galloway, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N Highland Ave, Murfreesboro, TN 37130 Phone: 800-596-3455 Fax: 615-396-6963 | |
Austin Wes Mackens, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Dr, Murfreesboro, TN 37129 Phone: 615-893-4480 Fax: 615-895-6212 | |
Jenifer L Tanner, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 N Highland Ave, Murfreesboro, Murfreesboro, TN 37130 Phone: 800-596-3455 Fax: 615-396-6963 | |
Dr. David Rodwell Whetstone, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N Highland Avenue, Middle Tennessee Medical Center Emergency Dept, Murfreesboro, TN 37130 Phone: 615-327-1818 Fax: 615-329-9479 |